The Substance Use/Substance Use Disorder Dissertation Research Award (R36) is a funding opportunity from the National Institutes of Health (NIH) aimed at supporting doctoral candidates for up to two years in their dissertation research related to substance use disorders. The award, under the National Institute on Drug Abuse (NIDA), encourages applications from diverse backgrounds and is designed for research that does not include leading an independent clinical trial. The funding's purpose includes advancing knowledge and approaches for the prevention, diagnosis, and treatment of substance misuse, drug overdose, and associated health outcomes. The program also emphasizes underrepresented groups in research. Applicants can receive up to $50,000 per year to conduct innovative research in various areas, including neuroscience, epidemiology, prevention, and treatment, all aligned with NIDA’s strategic plan. The application process requires strict adherence to NIH guidelines, with specific eligibility requirements and submission deadlines outlined. Applications will undergo peer review, focusing on the significance, innovation, and feasibility of the proposed research. The initiative underscores the NIH's commitment to fostering the next generation of researchers in the field of substance use and its related complexities.